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ABSTRACT
Objective: We present a case of a 27-year-old female trader with a month history of bilateral painless progressive blurring of vision which was worse 
for distant vision after a 4-year daily use of oral prednisolone (10 mg) prescribed by a non-ophthalmologist. The conventional treatment for ocular 
allergy includes avoidance of allergens, topical antihistamines, mast cell stabilizers, topical corticosteroids, oral antihistamines, nonsteroidal anti-
inflammatory drugs, and corticosteroids. However, inappropriate steroid use can be associated with undesirable complications.
Methods: A case report of a 27 year old female trader who presented with blurring of vision associated with glare at night. There was history of daily 
intake of oral prednisolone for 4 years for treatment of allergic conjunctivitis.
Results: Examination revealed posterior subcapsular cataract due to prolonged steroid use. Steroid was gradually tapered and withdrawn over a 
week and the patient was refracted with good visual improvement.
Conclusion: Steroids should be reserved for severe cases and when utilized should be used as pulsed or short course therapy after baseline 
examination by Ophthalmologists.
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INTRODUCTION
Steroids are drugs of relevance in ophthalmic care due to their anti-
inflammatory properties. Their routes of administration vary with the 
desired effect and severity of condition under treatment. They can be 
used as topical, subconjunctival, subtenon, intravitreal, intramuscular, 
intralesional, or intravenous preparations. Inappropriate or prolonged 
use can be associated with undesirable complications. The rationale for 
this case report is to discourage the inappropriate use of steroids and 
shows that prolonged steroid use can cause complications.
CASE REPORT
We present a case of a 27-year-old female trader with 1 month history 
of bilateral painless progressive blurring of vision which was worse 
for distant vision. There was no preceding history of ocular trauma. 
There was a history of recurrent itching which had been on for about 4 
years with associated tearing, redness, and foreign body sensation. The 
patient also reported a history of glare at night and diplopia on straight 
gaze but had no history of past spectacle wear or surgery. She was 
not a known diabetic, asthmatic, or peptic ulcer disease patient. She 
reported the use of oral prednisolone (10 mg) daily for about 4 years 
up till the time of presentation. The drug was said to have been initially 
prescribed by a medical practitioner for a week duration, but she 
continued to procure the same over-the-counter when she observed 
it helped to alleviate her symptoms. There was no family history of 
blindness or any other eye disease. The patient neither smoke cigarette 
nor drink alcohol.
Examination revealed a young adult woman with no pallor, jaundice, 
or sickle cell habitus. Unaided visual acuity was 6/6−2 on the right eye 
and 6/9−3 on the left eye. Other ocular findings were essentially normal 
apart from the presence of fine tarsal papillae and opacities in the 
posterior subcapsular region (Fig. 1)
Intraocular pressure measured with Goldmann applanation tonometer 
was 12 mmHg in either eye. An assessment of posterior subcapsular 
cataract secondary to prolonged steroid with allergic conjunctivitis was 
made. Steroid was gradually tapered and withdrawn over a week. The 
patient was commenced on gutt antazoline with tetrahydrozoline to 
be used 4 times daily. The result of the random blood sugar done was 
4 mmol/L. The refraction result revealed visual improvement to 6/5 
with plano/−0.50 axis 90 in both eyes.
DISCUSSION
Allergies are usual causes of conjunctivitis [1]. Allergic conjunctivitis is 
a common disorder as it affects about 40–80% of the world population 
of allergic diseases [2]. Its prevalence has been observed to be on 
the increase in today’s industrialized world [3]. The conventional 
treatment for ocular allergy includes avoidance of allergens, topical 
antihistamines, mast cell stabilizers, topical corticosteroids, oral 
antihistamine [4], nonsteroidal anti-inflammatory drugs, and 
corticosteroids. A few cases may require surgical intervention, 
especially in severe cases with corneal complications such as ulcer or 
opacities [5]. A potential therapeutic drop was reported by Satyam 
et al., 2014, but it was still at the trial phase in animals [6]. Steroid 
use in cases of allergies is due to its anti-inflammatory properties due 
to its ability to prevent the formation of arachidonic acid by blocking 
both the cyclooxygenase and lipooxygenase pathways. However, 
pulsed regimen is recommended to minimize the adverse effects of 
drugs. This patient had symptoms suggestive of allergic conjunctivitis 
on account, of which she was seen by a medical practitioner who was 
not an ophthalmologist. The practitioner gave a prescription for oral 
Prednisolone without first making recourse to topical antihistamines, 
mast cell stabilizers, or even topical nonsteroidal anti-inflammatory 
drugs. The mainstay of the management of ocular allergy involves the 
use of antiallergic therapeutic agents such as the antihistamines and 
mast cell stabilizers [7]. Our patient after exhausting the short course 
of prescribed oral prednisolone continued on self-medication for over 
4 years. The risk of ocular adverse effects makes it necessary to use 
steroid for short period like 2 weeks [8]. Possible ocular adverse effects 
of prolonged steroid use include elevated intraocular pressure and 
cataracts. This makes it necessary to have a baseline eye examination 
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before commencing steroids when required on a long-term basis. This 
patient presented with glare at night and diplopia on straight gaze which 
was observed to be as a result of opacities in the posterior subcapsular 
region of the lens. Steroid-induced posterior subcapsular cataract is 
a documented effect of prolonged use of glucocorticoids [9,10]. The 
mechanisms for this opacification are not quite known but among those 
proposed are the effect of steroids on the balance of ocular cytokines 
and growth factors [10]. The vision reduction in this patient was more 
of quality reduction as the level of vision reduction was not so marked 
since visual acuity of 6/6−2 on the right eye and 6/9 on the left eye as 
well as the presence of diplopia on straight gaze. The level of visual 
acuity improved with optical correction with corrective lenses, but the 
quality of vision will be assessed during subsequent follow-up clinic 
visits.
CONCLUSION
Allergies are known common causes of conjunctivitis. Treatment of 
allergic conjunctivitis should be stratified with antihistamines and 
mast cell stabilizers as the first-line drugs. Steroids should be reserved 
for severe cases and when utilized should be used as pulsed or short 
course therapy after baseline examination by ophthalmologists. 
Ophthalmologists and allergists should be consulted when there are 
symptoms suggestive of ocular allergy. Steroid drugs should be added 
to the list of prescription medications due to the potentials of abuse 
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Fig. 1: Posterior subcapsular cataract due to inappropriate 
steroid use
